Search research articles
Contact Us
Filters
Showing results (321-330 of 334) with videos related to
Page
of 34
Sort By:
Acta Pharmacologica Sinica
|
April 14, 2021
Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase
Wen Li, Li-Ping Liao, Ning Song, et al.
Medicine
|
February 18, 2016
Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study
Li-Ming Zhu, Laura Tang, Xin-Wei Qiao, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 11, 2005
Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression
Qing-Li Wu, Yun-Feng Fu, Wen-Liang Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 4, 2014
α-Internexin: a novel biomarker for pancreatic neuroendocrine tumor aggressiveness
Bei Liu, Laura H Tang, Zhaojun Liu, et al.
Acta Pharmacologica Sinica
|
April 14, 2021
P300/CBP inhibition sensitizes mantle cell lymphoma to PI3Kδ inhibitor idelalisib
Xiao-Ru Zhou, Xiao Li, Li-Ping Liao, et al.
The Journal of Organic Chemistry
|
July 18, 2025
Development of a Scalable Synthesis of a HPK1 Inhibitor Featuring a Direct α-Arylation of Boc-Protected <i>N,N</i>-Dimethylamine by Palladium-Mediated Negishi Cross-Coupling
Dahui Zhou, Matthew Del Bel, Thomas Knauber, et al.
Genome Biology
|
July 2, 2025
Deciphering gene regulatory programs in mouse embryonic skin through single-cell multiomics analysis
Qiuting Deng, Pengfei Cai, Yingjie Luo, et al.
Journal of Medicinal Chemistry
|
April 5, 2002
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics
Peter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 12, 2023
A Novel Cargo Delivery System-AnCar-Exo<sup>LaIMTS</sup> Ameliorates Arthritis via Specifically Targeting Pro-Inflammatory Macrophages
Song Li, Ya-Ran Wu, Xiu-Qin Peng, et al.
Journal of Medicinal Chemistry
|
March 14, 2017
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR
Simon Planken, Douglas C Behenna, Sajiv K Nair, et al.
Page
of 34
Search research articles
Search
Showing results (321-330 of 334) with videos related to
Sort By:
Page
of 34
Acta Pharmacologica Sinica
|
April 14, 2021
Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase
Wen Li, Li-Ping Liao, Ning Song, et al.
Medicine
|
February 18, 2016
Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study
Li-Ming Zhu, Laura Tang, Xin-Wei Qiao, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 11, 2005
Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression
Qing-Li Wu, Yun-Feng Fu, Wen-Liang Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 4, 2014
α-Internexin: a novel biomarker for pancreatic neuroendocrine tumor aggressiveness
Bei Liu, Laura H Tang, Zhaojun Liu, et al.
Acta Pharmacologica Sinica
|
April 14, 2021
P300/CBP inhibition sensitizes mantle cell lymphoma to PI3Kδ inhibitor idelalisib
Xiao-Ru Zhou, Xiao Li, Li-Ping Liao, et al.
The Journal of Organic Chemistry
|
July 18, 2025
Development of a Scalable Synthesis of a HPK1 Inhibitor Featuring a Direct α-Arylation of Boc-Protected <i>N,N</i>-Dimethylamine by Palladium-Mediated Negishi Cross-Coupling
Dahui Zhou, Matthew Del Bel, Thomas Knauber, et al.
Genome Biology
|
July 2, 2025
Deciphering gene regulatory programs in mouse embryonic skin through single-cell multiomics analysis
Qiuting Deng, Pengfei Cai, Yingjie Luo, et al.
Journal of Medicinal Chemistry
|
April 5, 2002
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics
Peter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 12, 2023
A Novel Cargo Delivery System-AnCar-Exo<sup>LaIMTS</sup> Ameliorates Arthritis via Specifically Targeting Pro-Inflammatory Macrophages
Song Li, Ya-Ran Wu, Xiu-Qin Peng, et al.
Journal of Medicinal Chemistry
|
March 14, 2017
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR
Simon Planken, Douglas C Behenna, Sajiv K Nair, et al.
Page
of 34